R

Reneo Pharmaceuticals

43 employees

Reneo Pharmaceuticals is an operator of a pharmaceutical company used to develop therapies for patients with orphan metabolic diseases.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Rare Diseases
Pharmaceutical
Mitochondrial Diseases
Primary Mitochondrial Myopathy

Date founded

2017

Funding rounds raised

Total raised

$95M

from 9 investors over 9 rounds

R

Reneo Pharmaceuticals raised $95M on December 9, 2020

Investors: Aisling Capital, RiverVest Venture Partners, Chiesi Ventures, Lundbeckfonden / Lundbeck Foundation, Pappas Capital and Abingworth

R

Reneo Pharmaceuticals raised $50M on May 20, 2019

Investors: RiverVest Venture Partners, Lundbeckfonden / Lundbeck Foundation and Pappas Capital

FAQ